Challenges in Development of Targeted Liposomal Therapeutics
- 14 March 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 14 (2), 303-315
- https://doi.org/10.1208/s12248-012-9330-0
Abstract
Liposomes, phospholipid vesicles with a bilayered membrane structure, have been widely used as pharmaceutical carriers for drugs and genes, in particular for treatment of cancer. To enhance the efficacy of the liposomal drugs, drug-loaded liposomes are targeted to the tumors by means of passive (enhanced permeability and retention mediated) targeting, based on the longevity of liposomes in blood and its accumulation in pathological sites with compromised vasculature, and active targeting, based on the attachment of specific ligands to the liposomal surface to bind certain antigens on the target cells. Antibody-targeted liposomes loaded with anticancer drugs demonstrate high potential for clinical applications. This review highlights evolution of liposomes for both passive and active targeting and challenges in development of targeted liposomal therapeutics specifically antibody-targeted liposomes.Keywords
This publication has 144 references indexed in Scilit:
- Targeted delivery of doxorubicin using stealth liposomes modified with transferrinInternational Journal of Pharmaceutics, 2009
- Multifunctional and stimuli-sensitive pharmaceutical nanocarriersEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Drug targeting and tumor heterogeneityJournal of Controlled Release, 2009
- Cytoplasmic Delivery of Liposomal Contents Mediated by an Acid-Labile Cholesterol-Vinyl Ether-PEG ConjugateBioconjugate Chemistry, 2008
- Tumor-Specific Anti-Nucleosome Antibody Improves Therapeutic Efficacy of Doxorubicin-Loaded Long-Circulating Liposomes against Primary and Metastatic Tumor in MiceMolecular Pharmaceutics, 2008
- Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell linesEuropean Journal of Pharmaceutical Sciences, 2007
- Design, Synthesis, and Characterization of pH-Sensitive PEG−PE Conjugates for Stimuli-Sensitive Pharmaceutical Nanocarriers: The Effect of Substitutes at the Hydrazone Linkage on the pH Stability of PEG−PE ConjugatesBioconjugate Chemistry, 2007
- Enhanced transfection of tumor cellsin vivousing “Smart” pH-sensitive TAT-modified pegylated liposomesJournal of Drug Targeting, 2007
- “SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical NanocarriersBioconjugate Chemistry, 2006
- Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol componentsLife Sciences, 1982